Drug approval prediction based on the discrepancy in gene perturbation effects between cells and humansResearch in context
Summary: Background: Poor translation between in vitro and clinical studies due to the cells/humans discrepancy in drug target perturbation effects leads to safety failures in clinical trials, thus increasing drug development costs and reducing patients’ life quality. Therefore, developing a predic...
Main Authors: | Minhyuk Park, Donghyo Kim, Inhae Kim, Sin-Hyeog Im, Sanguk Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-08-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396423002700 |
Similar Items
-
Drugs approved by CDSCO, India in 2015
by: K Parushuram Naik1 , V Sai Lakshmi2 , J Jyothirmai3
Published: (2016-04-01) -
A review of new drugs approved by the food and drug administration in 2022
by: Arjun Swaminathan, et al.
Published: (2023-01-01) -
Molecular docking of monkeypox (mpox) virus proteinase with FDA approved lead molecules
by: M.Valan Arasu, et al.
Published: (2023-05-01) -
Trends in FDA drug approvals over last 2 decades: An observational study
by: Angelika Batta, et al.
Published: (2020-01-01) -
A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers
by: Kaifeng Liu, et al.
Published: (2024-03-01)